The future is now!

Congratulations to the Feng Lab, and to Meng Zhang for leading this project! Each of you is a big part of the achievements of the lab and of your colleagues - thank you for being a wonderful team. You're the best! nature.com/articles/s4155…

“It would be a huge mistake to blame poor individual choices for smoking-related illnesses or obesity, when the real issue is that we have a sick society” Exactly! And don't forget that "health" and "green" industry can cause unnecesarry distress as well.

Interesting paper! Notably, prostate cancer patients in the older age group (75-84) do well on watchful waiting as well (depending on comorbidities and life expectancy of course) and they do not die in #prostatecancer...

Nice work! Interestingly, despite 60% ORR of BRCA2 mutants, the majority of them did not have durable response. Only 1 out of 5 patient with a ToT more than 10 months was BRCA2 carrier.

"Oldie" but goldie! Glad to see the progress in platinum #chemotherapy for #BRCA #prostatecancer since then: europeanurology.com/article/S0302-… Tibor Szarvas Nyirády Dr. Péter

Check out our recent paper this time on #bladdercancer! Shahrokh F. Shariat Jakob Klemm Urologic Oncology Research MedUni Vienna MedUni Wien mdpi.com/2077-0383/13/1…

Excited to share our manuscript addressing a novel linkage between the Decipher genomic classifier and real-world clinical data with >92,000 patients securely linked jamanetwork.com/journals/jaman… Chris Filson Tyler Seibert MD PhD Decipher by Veracyte Elai Davicioni Matt Cooperberg

I am beyond excited to share our latest paper, published today in Cancer Cell, as the culmination of many years of work: cell.com/cancer-cell/fu…

If you are interested in #brca positive #prostatecancer our paper on #platinum #chemotherapy vs #parpi is for you! #olaparib #rucaprib #talazoparib #niraprib

As good as I've seen. Should be mandatory reading for all PCP's and urologists who screen for PrCa Prostate-specific antigen screening for prostate cancer: Diagnostic pe... sciencedirect.com/science/articl… Michael Leapman Preston Sprenkle, MD

We have a lot to do ☝🏼

A must read if you are interested in #kidneycancer ☝🏼 Congrats Bernadett Szabados!

"Research is about more than completing a series of discrete tasks as efficiently as possible. It is a cultural endeavour and a social practice." Wise thoughts on the utility of #ArtificialInteligence in #research! thelancet.com/journals/lance…

Exciting data on #Stockholm 3 vs #PSA in a diverse cohort of patients with suspicion of #ProstateCancer Stockholm3 reduced unnecessary biopsies by 45%, while exhibiting similar sensitivity for csPCa detection! However, MRI was utilized in only 16% of patients...

Outstanding review on the management of #brca carriers! #prostatecancer

Check out our latest paper: comparison of transrectal and transperineal #prostate biopsy!

Can we tackle uncertainty, anxiety and scanxiety? Are we ready to refer our #prostatecancer patients on #activesurveillance to #psychotherapy to help with distress? #mindfullness #meditation #behavioral_therapy

Wrapping up an incredible one-year #research fellowship in #Vienna! I'm beyond grateful to have been part of this amazing team and for the invaluable guidance from Shahrokh F. Shariat and Pawel Rajwa! Thank you all for this unforgettable journey—there is more to come! 🚀

Addition of ARPIs to ADT increases the risk of cardiac disorders( ie., IHD, AF, & hypertension). Each ARPI exhibits a distinct cardiovascular event profile. Selecting patients carefully & vigilant monitoring for cardiovascular issues is imperative. nature.com/articles/s4139…